Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2021

Jul 20, 2021

SELL
$259.0 - $414.71 $261,590 - $418,857
-1,010 Closed
0 $0
Q1 2021

Apr 14, 2021

BUY
$242.95 - $284.63 $728 - $853
3 Added 0.3%
1,010 $282,000
Q4 2020

Jan 22, 2021

SELL
$236.26 - $355.63 $78,438 - $118,069
-332 Reduced 24.79%
1,007 $246,000
Q3 2020

Oct 27, 2020

SELL
$264.77 - $305.71 $27,800 - $32,099
-105 Reduced 7.27%
1,339 $380,000
Q2 2020

Jul 20, 2020

SELL
$258.66 - $342.55 $128,036 - $169,562
-495 Reduced 25.53%
1,444 $386,000
Q1 2020

Apr 22, 2020

SELL
$268.85 - $341.04 $108,884 - $138,121
-405 Reduced 17.28%
1,939 $614,000
Q4 2019

Jan 29, 2020

SELL
$220.06 - $304.07 $348,795 - $481,950
-1,585 Reduced 40.34%
2,344 $695,000
Q3 2019

Oct 28, 2019

SELL
$217.44 - $243.88 $390,739 - $438,252
-1,797 Reduced 31.38%
3,929 $915,000
Q2 2019

Aug 05, 2019

SELL
$219.29 - $241.72 $335,952 - $370,315
-1,532 Reduced 21.11%
5,726 $1.34 Million
Q1 2019

Apr 19, 2019

SELL
$216.71 - $338.96 $19,503 - $30,506
-90 Reduced 1.22%
7,258 $1.72 Million
Q4 2018

Jan 25, 2019

SELL
$278.5 - $352.75 $20,887 - $26,456
-75 Reduced 1.01%
7,348 $2.21 Million
Q3 2018

Dec 13, 2018

SELL
$293.51 - $383.83 $183,443 - $239,893
-625 Reduced 7.77%
7,423 $2.62 Million
Q2 2018

Dec 12, 2018

BUY
$257.52 - $306.91 $137,773 - $164,196
535 Added 7.12%
8,048 $2.34 Million
Q1 2018

Dec 21, 2018

BUY
$260.13 - $367.91 $221,110 - $312,723
850 Added 12.76%
7,513 $2.06 Million
Q4 2017

Dec 26, 2018

BUY
$307.64 - $344.58 $2.05 Million - $2.3 Million
6,663
6,663 $2.12 Million

Others Institutions Holding BIIB

About BIOGEN INC.


  • Ticker BIIB
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 144,000,992
  • Market Cap $25B
  • Description
  • Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...
More about BIIB
Track This Portfolio

Track Plimoth Trust CO LLC Portfolio

Follow Plimoth Trust CO LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Plimoth Trust CO LLC, based on Form 13F filings with the SEC.

News

Stay updated on Plimoth Trust CO LLC with notifications on news.